Cell therapy holds promise in improving outcomes for many difficult-to-treat diseases. However, this therapeutic strategy also comes with challenges that limit rollouts on a more impactful scale. Cell material is difficult to handle and maintain. Establishing a scalable and reliable manufacturing workflow is complex and very expensive, making the cost of developing and delivering cell therapies prohibitive. Furthermore, quality control processes for cell-based therapeutics pose unique issues compared to traditional pharmaceutical manufacturing. This webinar demonstrates how a streamlined solution that combines equipment, software and training can help tackle many of these challenges. Find out how to make cell manufacturing simpler and safer by automating custom processes on a closed platform, building bias-free quality control, and planning protocol-aligned training for your staff. The upshot is an easier transition from research to manufacturing.